The Trajectory of the COVID-19 Vaccine Antibody Titers Over Time and the Association of Mycophenolate Mofetil in Solid Organ Transplant Recipients

被引:2
|
作者
Sakai, Akiyoshi [1 ]
Morishita, Tetsuji [2 ,3 ,10 ]
Suzumuraa, Kaori [1 ]
Hanatate, Fumika [4 ]
Yoshikawa, Tomomi [3 ]
Sasaki, Noriko [3 ]
Lee, Shin [5 ]
Fujita, Kei [5 ]
Hara, Takeshi [5 ]
Araki, Hiroshi [6 ]
Tagami, Atsushi [6 ]
Murayama, Masanori [2 ]
Yamada, Rie [2 ]
Iwata, Akira [2 ]
Sobajima, Takuya [2 ]
Kasahara, Yukiko [7 ]
Matsuzawa, Yoriko [7 ]
Takemura, Masao [8 ]
Yamamoto, Yasuko [8 ]
Fujigakih, Hidetsugu [8 ]
Saitoh, Kuniaki [8 ]
Tsurumii, Hisashi [9 ]
Matsunamii, Hidetoshi [9 ]
机构
[1] Matsunami Gen Hosp, Dept Clin Lab, Gifu, Japan
[2] Matsunami Gen Hosp, Dept Internal Med, Gifu, Japan
[3] Matsunami Res Pk, Gifu, Japan
[4] Matsunami Gen Hosp, Dept Breast Surg, Gifu, Japan
[5] Matsunami Gen Hosp, Dept Hematol, Gifu, Japan
[6] Matsunami Gen Hosp, Dept Gastroenterol, Gifu, Japan
[7] Matsunami Gen Hosp, Dept Pediat, Gifu, Japan
[8] Fujita Hlth Univ, Dept Adv Diagnost Syst Dev, Grad Sch Hlth Sci, Toyoake, Aichi, Japan
[9] Matsunami Gen Hosp, Gifu, Japan
[10] Matsunami Gen Hosp, Internal Med, 185-1 Dendai, Kasamatsu, Gifu 5016062, Japan
关键词
D O I
10.1016/j.transproceed.2022.10.023
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The COVID-19 vaccine will be safe and effective in solid organ transplant recipients (SOTs). However, the blunted antibody responses were also of concern. Few studies have reported prolonged serologic follow-up after 2 doses of BNT162b2 vaccine in SOTs. We performed a sin-gle-center, prospective observational study of 78 SOTs who received 2 doses of BNT162b2 vac-cine. We identified the trajectory of antibody titers after vaccination among SOTs with or without mycophenolate mofetil (MMF) or withdrawn from MMF. We found low seroconversion rates (29/42: 69%) and low antibody titers in SOTs treated with MMF. An inverse linear relation-ship between neutralizing antibody titers and MMF concentration was confirmed in restricted cubic spline plots (P for effect < .01, P for nonlinearity = .08). For the trajectory of antibody responses, seroconversion and improved antibody titers were observed after withdrawal from MMF in SOTs who showed seronegative or low antibody titers at the first visit after 2 doses of vaccine (P for effect < .01, P for nonlinearity < .05, and P for interaction < .01). We identified increased B-cell counts after withdrawal from MMF (P < .01). The recovery of antibody responses was seen in SOTs withdrawn from MMF. The trajectories of antibody responses were modified by MMF administration.
引用
收藏
页码:2638 / 2645
页数:8
相关论文
共 50 条
  • [1] Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients
    Boyarsky, Brian J.
    Chiang, Teresa P. -Y.
    Ou, Michael T.
    Werbel, William A.
    Massie, Allan B.
    Segev, Dorry L.
    Garonzik-Wang, Jacqueline M.
    TRANSPLANTATION, 2021, 105 (08) : E82 - E83
  • [2] Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
    Yetmar, Z. A.
    Beam, E.
    O'Horo, J. C.
    Ganesh, R.
    Bierle, D. M.
    Brumble, L.
    Seville, M. T.
    Razonable, R. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 419 - 419
  • [3] Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients
    Sarrell, Bonnie Ann
    Bloch, Karen
    El Chediak, Alissar
    Kumm, Kayla
    Tracy, Kaitlyn
    Forbes, Rachel C.
    Langone, Anthony
    Thomas, Lora
    Schlendorf, Kelly
    Trindade, Anil J.
    Perri, Roman
    Wright, Patty
    Concepcion, Beatrice P.
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (01)
  • [4] Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients
    Yetmar, Zachary A.
    Beam, Elena
    O'Horo, John C.
    Ganesh, Ravindra
    Bierle, Dennis M.
    Brumble, Lisa
    Seville, Maria Teresa
    Razonable, Raymund R.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (06):
  • [5] COVID-19 in solid organ transplant recipients
    Giorgakis, Emmanouil
    Zehtaban, Shannon P.
    Stevens, Amanda E.
    Bhusal, Sushma
    Burdine, Lyle
    TRANSPLANT INFECTIOUS DISEASE, 2021, 23 (01)
  • [6] Third Time's a Charm - Covid-19 Vaccine Hope for Solid-Organ Transplant Recipients
    Williams, Winfred W.
    Ingelfinger, Julie R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (13): : 1233 - 1234
  • [7] Reduction of mycophenolate mofetil dosage to limit prolonged viral shedding in solid organ transplant recipients with COVID-19: Two case reports
    Murai, Yushi
    Sakao, Seiichiro
    Kure, Fujihiro
    Kawasaki, Takeshi
    Maruyama, Michihiro
    Suzuki, Hidemi
    Yoshino, Ichiro
    Suzuki, Takuji
    RESPIRATORY INVESTIGATION, 2024, 62 (01) : 98 - 101
  • [8] Antivirals for COVID-19 in Solid Organ Transplant Recipients
    Justin C. Laracy
    Elizabeth C. Verna
    Marcus R. Pereira
    Current Transplantation Reports, 2020, 7 : 355 - 365
  • [9] Antivirals for COVID-19 in Solid Organ Transplant Recipients
    Laracy, Justin C.
    Verna, Elizabeth C.
    Pereira, Marcus R.
    CURRENT TRANSPLANTATION REPORTS, 2020, 7 (04) : 355 - 365
  • [10] Impact of COVID-19 in solid organ transplant recipients
    Danziger-Isakov, Lara
    Blumberg, Emily A.
    Manuel, Oriol
    Sester, Martina
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (03) : 925 - 937